B+
Bull case
30%
Probability
Target price
$350.00
Analysis reference price unavailable
Analysis 2026-10-26 · RankAlpha Sentiment Codex
CME
CME GroupBNasdaq / Financial Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$320.00
Analysis reference price unavailable
Analysis 2026-10-26 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$260.00
Analysis reference price unavailable
Analysis 2026-10-26 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-10-26
Recent news sentiment (30D)
+3.0
Mixed
Company
-
Unavailable
Macro
+3.0
Mixed
Pulse
-
Unavailable
Weekly research (10D)
-20.0
Negative
Sentiment proxy
+68.1
Score
AI commentary
The Q3 release and post-print analyst target increases support positive news tone, but the reported consensus beat was small. Secondary coverage reports a roughly 3.5% October 22 share-price rise; the $305.71 October 23 anchor is close to that reported post-print level, suggesting the initial gain largely held through Friday. The packet contains no sufficient social, options-skew, short-interest or employee-score evidence; zeros in the sentiment object are unavailable-data placeholders, not measured neutral readings. Target aggregators disagree and forward-estimate revision detail is limited. post-print price account analyst actions
RankAlpha Sentiment Codex - 2026-10-26
Open post-earnings memoEvidence flagged
peer set is too generic or lacks enough direct operating comparators
Impact
tentative
Confidence
-
AI events
2026-11-30catalystQ3 earnings strength meets a higher valuation barMedium impact
CME reported record Q3 revenue of about $1.7 billion, adjusted EPS of $3.02, and 29.4 million average daily contracts, with double-digit volume growth across all six asset classes. Secondary consensus data indicate a modest beat—$1.74 billion versus $1.72 billion revenue and $3.02 versus $2.99 adjusted EPS—rather than a large surprise. The follow-up test is whether October volume and fee capture sustain the earnings run-rate after the initial share-price rise. [#SEC-8K-2026-10-21] CME earnings exhibit
2026-12-07eventTreasury clearing launchMedium impact
CME's Q3 commentary targets a December 7 launch of CME Securities Clearing, subject to necessary regulatory approvals. Launch and subsequent client adoption—not the announced date alone—would test monetization of Treasury cash and repo clearing. [#IR-Q3-2026-COMMENTARY] CME Q3 commentary
2026-12-31eventFourth-quarter fee and product follow-throughMedium impact
CME says its October 1 transaction-fee changes would add approximately 0.5%-1% to clearing and transaction fees on a full-year basis at activity comparable to year-to-date 2026. Compute futures are targeted for Q4, pending regulatory review. Both depend on activity and execution rather than guaranteed incremental revenue. [#IR-Q3-2026-COMMENTARY] CME Q3 commentary
Recommendation
N/A
No formal recommendation provided.
As of 2026-10-26 • Updated nightlySource: Internal modelMethodology